Cart
sales@molnova.com
Naloxegol oxalate
CAS No. 1354744-91-4
Naloxegol oxalate ( AZ 13337019; NKTR-118 )
Catalog No. M11448 CAS No. 1354744-91-4
Naloxegol (NKTR-118 and AZ-13337019), is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 90 | In Stock |
|
| 10MG | 131 | In Stock |
|
| 25MG | 218 | In Stock |
|
| 50MG | 322 | In Stock |
|
| 100MG | 479 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNaloxegol oxalate
-
NoteResearch use only, not for human use.
-
Brief DescriptionNaloxegol (NKTR-118 and AZ-13337019), is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation.
-
DescriptionNaloxegol (NKTR-118 and AZ-13337019), is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation. It was approved in 2014 in adult patients with chronic, non-Y pain. Chemically, naloxegol is a pegylated (polyethylene glycol-modified) derivative of α-naloxol. Specifically, the 5-α-hydroxyl group of α-naloxol is connected via an ether linkage to the free hydroxyl group of a monomethoxy-terminated n=7 oligomer of PEG.
-
SynonymsAZ 13337019; NKTR-118
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP3A
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1354744-91-4
-
Formula Weight741.83
-
Molecular FormulaC36H55NO15
-
Purity>98%(HPLC)
-
SolubilityDMSO：≥ 40 mg/mL
-
SMILESCOCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC=C)O.C(=O)(C(=O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bui K, et al. J Clin Pharmacol. 2016 Aug;56(8):1019-27.
molnova catalog
related products
-
Ginsenoside Rb3
Ginsenoside Rb3 is a natural triterpenoid saponin, exhibiting inhibition effect on TNFα-induced NF-κB transcriptional activity. It also inhibits the induction of COX-2 and iNOS mRNA.
-
AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor(IC50 :1.9 nM). AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
-
Mephenytoin
Mephenytoin is an anticonvulsant and a substrate of CYP2C19 and CYP2B6.
